Cargando…

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease

Sickle cell disease (SCD) is caused by a mutation (E6V) in the hemoglobin (Hb) β-chain that induces polymerization of Hb tetramers, red blood cell deformation, ischemia, anemia, and multiple organ damage. Gene therapy is a potential alternative to human leukocyte antigen (HLA)-matched allogeneic hem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poletti, Valentina, Urbinati, Fabrizia, Charrier, Sabine, Corre, Guillaume, Hollis, Roger P., Campo Fernandez, Beatriz, Martin, Samia, Rothe, Michael, Schambach, Axel, Kohn, Donald B., Mavilio, Fulvio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276308/ https://www.ncbi.nlm.nih.gov/pubmed/30533448 http://dx.doi.org/10.1016/j.omtm.2018.10.014

Ejemplares similares

Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
por: Poletti, Valentina, et al.
Publicado: (2018)

An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype
por: Weber, Leslie, et al.
Publicado: (2018)

The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cells
por: Romero, Zulema, et al.
Publicado: (2015)

Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
por: Charrier, Sabine, et al.
Publicado: (2019)

Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
por: Poletti, Valentina, et al.
Publicado: (2021)

PGE2 and Poloxamer Synperonic F108 Enhance Transduction of Human HSPCs with a β-Globin Lentiviral Vector
por: Masiuk, Katelyn E., et al.
Publicado: (2019)

β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion Production
por: Han, Jiaying, et al.
Publicado: (2020)

Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy
por: Brendel, Christian, et al.
Publicado: (2020)

Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
por: Negre, Olivier, et al.
Publicado: (2015)

Sickle cell anemia: clinical diversity and beta S-globin haplotypes
por: Loggetto, Sandra Regina
Publicado: (2013)

Creating New β-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences
por: Morgan, Richard A., et al.
Publicado: (2020)

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling
por: De Souza, Daniel C., et al.
Publicado: (2023)

Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
por: Weber, Leslie, et al.
Publicado: (2020)

Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
por: Uchida, Naoya, et al.
Publicado: (2021)

The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34(+) Cells from Sickle Cell Disease Patients
por: Drakopoulou, Ekati, et al.
Publicado: (2022)

Biochemical and Molecular analysis of the beta-globin gene on Saudi sickle cell anemia
por: Alenzi, Faris Q., et al.
Publicado: (2019)

Frequency of beta S globin gene haplotypes among sickle cell patients in Nigeria
por: Adabale, Abosede, et al.
Publicado: (2021)

Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia
por: Nualkaew, Tiwaporn, et al.
Publicado: (2021)

The GATA1-HS2 Enhancer Allows Persistent and Position-Independent Expression of a β-globin Transgene
por: Miccio, Annarita, et al.
Publicado: (2011)

Influence of βS-Globin Haplotypes and Hydroxyurea on Arginase I Levels in Sickle Cell Disease
por: Moreira, J. A., et al.
Publicado: (2016)

Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations
por: Woodard, Kaitly J., et al.
Publicado: (2022)

βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for Ex Vivo Anti-sickling Activity in Human Erythroid Cells
por: Demirci, Selami, et al.
Publicado: (2020)

Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease
por: Raffield, Laura M., et al.
Publicado: (2018)

Beta-S globin haplotypes in patients with sickle cell anemia: one approach to understand the diversity in Brazil
por: Okumura, Jéssika Viviani, et al.
Publicado: (2013)

New variants in beta globin gene among the Palestinian refugees with sickle cell disease in Lebanon
por: Moussa, Esraa Y., et al.
Publicado: (2018)

Lentiviral Vectors with Amplified Beta Cell-Specific Gene Expression
por: Shaw, Kit L., et al.
Publicado: (2009)

Influence of βS-globin haplotypes hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia
por: Laurentino, Marília Rocha, et al.
Publicado: (2014)

Presence of atypical beta globin (HBB) gene cluster haplotypes in sickle cell anemia patients of India
por: Nongbri, Sandor Rudy L., et al.
Publicado: (2017)

Lentiviral standards to determine the sensitivity of assays that quantify lentiviral vector copy numbers and genomic insertion sites in cells
por: Corre, Guillaume, et al.
Publicado: (2022)

Comment on “Influence of βS-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia”
por: de Souza Torres, Lidiane
Publicado: (2014)

Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells
por: Pestina, Tamara I, et al.
Publicado: (2015)

Alpha‐globin gene triplication and its effect in beta‐thalassemia carrier, sickle cell trait, and healthy individual
por: Hamid, Mohammad, et al.
Publicado: (2021)

Systemic epigenetic response to recombinant lentiviral vectors independent of proviral integration
por: Aranyi, Tamas, et al.
Publicado: (2016)

Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector
por: Dahl, Maria, et al.
Publicado: (2020)

Haplotype of the β(S)-globin cluster in patients with sickle cell anemia at a University Hospital in the Triangulo Mineiro, Minas Gerais
por: Leal, Alexandra Silva, et al.
Publicado: (2015)

Characterization of Whole Blood Gene Expression Profiles as a Sequel to Globin mRNA Reduction in Patients with Sickle Cell Disease
por: Raghavachari, Nalini, et al.
Publicado: (2009)

Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
por: Park, So Hyun, et al.
Publicado: (2019)

Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice
por: Wilkinson, Adam C., et al.
Publicado: (2021)

Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells
por: Geis, Franziska K., et al.
Publicado: (2017)

Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5f8t3h99l2nomsc25icj4uqg7c